COVID-19 Pandemic
2020
Timeline of significant global, Australian and SA data points in the initial response and first year of the COVID-19 Pandemic.
Navigate the timeline pages:
1800s | 1900-1945 | 1946-1979 | 1980-1999 | 2000-2015 | 2016-2018 | 2019 | You Are Here | 2021 | 2022 | 2023 | 2024 | 2025
Quick links to months of 2020:
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sept | Oct | Nov | DecGive the page a couple of moments to load…it is long. Some of the links may not work due to the length! Best viewed on a large screen.
Two HCQ scientific papers retracted from 2 peer review journals – UNPRECEDENTED!
COVID-19 vaccine developers have a problem – not enough sick people
As early as May 22, 2020 the lack of infectious cases of COVID-19 was identified by Adrien Hill from Oxford’s Jenner institute when he said to Science mag “…we’re beginning to run out of good trial sites to do vaccine efficacy studies—even the U.S. is plateauing,” …People are going to fight for that site to get the vaccine tested before it runs out.” The disappearance of Ebola cases in November 2015 was a major problem for vaccine developers!
Then on June 10, 2020 the Washington Post reported that Oxford University officials who were rushing to “develop coronavirus vaccines are alerting governments, health officials and shareholders” that declining numbers of new infections may be getting too small to quickly determine whether vaccines work!
“Even as new cases are growing worldwide, transmission rates are falling in Britain, China and many of the hardest-hit regions in the United States — the three countries that have experimental vaccines ready to move into large-scale human testing in June, July and August.”
Volunteers need to be exposed to someone infected with the virus to determine if the vaccine works.
Australia’s first human vaccine trials begin
U.S. biotechnology company Novavax, via Nucleus Network, began injecting 6 Australian volunteers with their nanoparticle encapsulated “spike” protein recombinant coronavirus vaccine candidate (Novavax NVX-CoV2373) in Melbourne on Tuesday 26 May 2020. [1, 2, 3]
Novavax trials received funding support from CEPI.
NGO launched the “WHO Foundation”
WHO Foundation based in Geneva is an NGO founded by Prof. Dr Thomas Zeltner, who’s launch was announced at the WHO Covid-19 press conference on May 27th, 2020.
At first glance you’d think this organisation was part of the World Health Organisation, but it is legally independent, though bound by an Affiliation Agreement. It is a non-governmental, not-for-profit, organisation that was set up as a grant-making foundation to support and complement WHO’s resource mobilisation efforts to address the most critical global health issues.
The WHO Foundation jointly manages the COVID-19 Solidarity Response Fund (SRF) and the COVAX ACT Together Fund both with the UN Foundation (an NGO founded by CCN magnate). The former fund was initially it was set up with the Swiss Philanthropy Foundation.
The WHO Foundation appointed former Gates Foundation senior advisor, Anil Soni as its CEO effective January 1, 2021.
TOGETHER trials started by Gates Foundation
The TOGETHER trials were initiated in June 2020 (archives),with the Bill & Melinda Gates Foundation provided seed funding. By September 21, 2020 Cytel had designed the “novel platform” to coordinate the COVID-19 TOGETHER clinical trials looking at outpatient treatments. As of September 2020 “only 6 of 2000 trials are focused on early stages” for treating COVID-19 for a disease where “only 5% of coronavirus cases are considered severe”! [4]
The protocol published in October 2020 stated “An Adaptive Randomized Platform Trial to Investigate the Efficacy of Novel Agents for Treatment of SARS-CoV-2 Infection Among High-Risk Outpatient Adults in Low and Middle Income Countries”, which was to be conducted in Brazil and South Africa. [1] Initially looking at four different treatments against a “placebo” of vitamin C [5, 6] (which should itself be a treatment!)!
The Brazilian clinical trials were sponsored by cardiovascular “card” research, and started January 27, 2021. [9]
Protocol versions – HERE
Trial publications – HERE
The Cytel “platform” approach is designed to find effective treatments quickly but also to “eliminate poorly performing therapies” – as they did for hydroxychloroquine and ivermectin etc.
Cytel designed the trial tracking software [3], and the trials were funded by FTX Foundation [7, 8, 10], the Bill & Melinda Gates Foundation, the Rainwater Charitable Foundation, FastGrants, and UNITAID, [2] Both FTX (now bankrupt) and UNITAID sponsored the TOGETHER trials sometime after Dec. 3, 2021 and by March 2022.
Dr Kory speaks to the shenanigans of the TOGETHER trial on ivermectin – WATCH
Aust: No effective treatment for COVID-19
We are 4 months into a declared pandemic and Australia’s Health Minister Greg Hunt stated:
“There is currently no vaccine or proven and effective treatments for COVID-19.”
Yet American doctors are repurposing drugs, with known safety profiles for the doses use, to effectively treat COVID-19 symptoms to prevent hospitalisation. This off-label use of registered drugs, used within their known dosage is a common practice by US doctors and supported by the FDA.
Fauci: coronavirus vaccines may not provide long-term immunity
When talking with JAMA Editor Howard Bauchner, Dr. Anthony Fauci says there’s a chance the coronavirus vaccines may not provide long-term immunity, if COVID-19 acts like other coronaviruses, “it likely isn’t going to be a long duration of immunity”. [1]
At this point “scientists still don’t fully understand key aspects of the virus, including how immune systems respond once a person is exposed.”
At the same time member of the boards of Pfizer and former FDA commissioner, Dr Scott Gottlieb says expect COVID-19 vaccine to be seasonal like the flu shot.
Prince Charles & WEF launch “The Great Reset”
On June 3, 2020 The Prince of Wales’ Sustainable Markets Initiative, in partnership with the World Economic Forum (WEF) launched a major global initiative, #TheGreatReset. Prince Charles and Klaus Schwab openly advertised and launched “The Great Reset“. It is no conspiracy theory. Even Time Magazine, is helping it’s promotion to reset global capitalism and establish a new world order. [1, 2, 3, 4, 5, 6, 7, 8, 9, 10]
“The pandemic has provided an opportunity for a reset” they claim. An opportunity to “build back better” they claim. [11, 12]
At Davos 2021 “The Great Reset” was the focus, “a commitment to jointly and urgently build the foundations of our economic and social system for a more fair, sustainable and resilient future” [1] Digital ID , vaccination passport featured in the 2021 Davos Agenda. [2]
Two major medical journals retract HCQ papers on the same day
On June 4, 2020 two major scientific medical journal The Lancet [2] and the New England Journal of Medicine (NEJM) [3] both RECTACT studies on hydroxychloroquine where global data was allegedly supplied by Surgisphere the company represented by the author Sapan S Desai. [1]
See HCQ timeline for more information
Global Vaccine Summit – Launched IA2030 and pledged funds COVID-19 vaccine for “developing world”
On June 4, 2020 the UK hosted the GAVI virtual Global Vaccine Summit where world leaders pledged financial commitment for “equitable immunisation coverage and global health security in the face of the COVID-19 pandemic”.
- Australia pledged $244 million
Oxfam expected this Vaccine Alliance pledging conference “to raise at least US$ 7.4 billion to support the roll out of vaccination programs across the developing world, and establish a new fund to help developing countries buy and distribute a coronavirus vaccine.”
At the summit the Immunisation Agenda 2030 (IA2030) officially launched, that is the new decade of vaccines, the “utopia” goal from 2015, to achieve “a world where everyone, everywhere, at every age, fully benefits from vaccines for good health“.
Gavi COVAX AMC 92 set up the financial arm to finance COVID-19 vaccines for developing nations
At the June 4, 2020 at the virtual Global Vaccine Summit pledging event, Gavi launched the Gavi COVAX AMC as an “investment opportunity” and first building block of the COVAX Facility. A required “financial mechanism” so that the world’s poorest countries will get access to COVID-19 vaccines. It required $2 billion to starting investment. [1]
Gavi coordinated and raised funds for the COVAX AMC, an innovative financing instrument that supported the participation of 92 lower-income economies in the COVAX Facility.
“The goal is by the end of 2021 to deliver two billion doses of safe, effective vaccines to all participating countries including the 92 AMC-eligible economies. Once a vaccine has been approved by regulatory agencies and/or prequalified by the WHO, the COVAX Facility will then purchase these vaccines with a goal to try and initially provide doses for an average of 20% of each country’s population, focusing on health care workers and the most vulnerable groups.”
- The COVAX facility documents were released August 2020
- On top of 2020 funding, more pledges were made to COVAX initiative at 2021 G7 summit
- COVAX AMC 92 framework
- Gavi plan to push COVID-19 vaccines into 2024-25
- By 2024 Gavi has raised more than US$12 billion in donor funding for the AMC
Warp Speed chooses 5 vaccine candidates
On June 5, 2020, the Operation Warp Speed (OWSVI) had chosen 5 vaccine candidates: Moderna, Oxford/AstraZeneca, Johnson & Johnson, Merck and Pfizer, the first three having already received $2.2 billion in federal funding. [1, 2]
Former FDA chief Scott Gottlieb, and Pfizer board member, pointed out Sanofi and Novavax were absent from the list. Paul Offit also questions “the lack of diversity in the five selected vaccines, which rely on just three different technologies.” An unnamed source connected to the selection process said “It’s been so chaotic, and it’s not even transparent to those of us who are trying to help out.”
“The move appeared to signal that Warp Speed had changed its initial plan of doing comparative studies of 14 vaccines it said last month that it had singled out from the more than 100 candidates in development at companies and universities.”
Australia PHLN guidance, up to 45 cycles for PCR tests
From June 8, 2020, the Australian Government’s Public Health Laboratory Network (PHLN) put out guidance on Nucleic Acid Test Result Interpretation for SARS-CoV-2 in the laboratory. They state that with PCR tests for SARS-CoV-2 “usually 35-45 cycles are undertaken”, and make the comment that over 40 can risk false positive.
WHO: Asymptomatic transmission “very rare” – then backtracks
On June 9, 2020 Dr Maria Van Kerkhove, head of the World Health Organization’s emerging diseases and zoonosis unit, said transmission of the coronavirus by people who aren’t showing symptoms (asymptomatic) is “very rare“, then backtracks, “much is still unknown“! [2]
Modelling studies estimate as many as 40% of “infections” could be transmitted by people “who have the virus [PCR positive!] but no symptoms”. [1]
Talk begins to lower the expectation of a COVID-19 vaccine end goal
Around mid June 15 (May to July 2020) as animal studies and Stage 1 & 2 COVID-19 vaccine trial results start to trickle in, talk begins to lower the expectation of the COVID-19 vaccines, from preventing infection or transmitting of the virus to protecting you from serious illness, hospitalisation or death – a different end point. [1] All initially fueled the only solution to provide is a “preventive shot as the route to return to pre-pandemic life.” This is curious since most people have no symptoms and need to get a PCR test to determine if they a “positive” for the virus!
Traditionally vaccines create neutralising immunity to stop the virus from infecting you, making you sick and your ability to transmit the pathogen. That is the reason health authorities call them “immunisation programs” as they are meant to provide “steriliing immunity”. Though influenza vaccines don’t meet that expectation so they begin comparing a COVID-19 vaccine to a flu shot.
“Experts say such a product [that only stops severe symptoms] would probably be widely used if approved, even if that’s as much as it contributes, until a more effective version comes to market.”…“Vaccines need to protect against disease, not necessarily infection, said Dennis Burton, an immunologist and vaccine researcher at Scripps Research in La Jolla, California.”
The public now needs to be re-trained as to what “protection” means!
A new gene technology product, categorised as “vaccines” began human trials in 2020, but as the data emerges the scientist realise it can’t deliver on the expectations of a traditional vaccine.
FDA revokes EUA for Hydroxychloroquine
Emergency Use Authorization (EUA) for hydroxychloroquine‘s use for COVID-19 was revoked by the FDA “after trials showed it was ineffective and the FDA got reports of heart problems caused by the drug.” [1, 2] EUA was granted on March 28,2020.
The clinical trials used “potentially lethal” doses of hydroxychloroquine in hospitalised patients, contrary to use by frontline doctors who use the drug early, in combination with zinc and in normal, lower doses. [3]
The heart arrhythmia problems were reported in a fraudulent paper published in The Lancet on May 22, 2020 which was retracted just 14 days later.
US: Saline Placebo Control Group is demanded for COVID-19 vaccine clinical trials
On June 17, 2020 Aaron Siri’s law firm on behalf of ICAN sent a Citizen Petition to the FDA demanding “that all Phase II and III COVID-19 vaccine trials include a placebo control group, that the placebo should be a saline injection without anything added, and that the placebo control group be at least equivalent in size to the experimental group”. [1]
Two days later on June 19, 2020 the FDA updated their “development and licensure” Guidelines for Industry
The petition also requested:
“All systemic adverse reactions, adverse events, serious adverse events, medically-attended adverse events, new onset medical conditions, and any other health issue arising or exacerbated post-vaccination shall be documented for each subject post-vaccination for a period of at least twelve months for adults, thirty-six months for children and teenagers, and sixty months for infants and toddlers.”
The FDA failed this as the placebo arm was unblined on Dec 14, 2020 for Pfizer/BioNTech and January 14, 2021 for Moderna so no long term safety signals will ever be determined “causative”. [1]
FDA releases COVID-19 vaccine “development and licensure” Guidelines for Industry
June 19, 2020 the FDA published the “Guidance for Industry” document for the “Development and Licensure of Vaccines to Prevent COVID-19“. [1]
This follows the March 25, 2020 notice in the Federal Register (85 FR 16949) titled “Process for Making Available Guidance Documents Related to Coronavirus Disease 2019”.[1]
The FDA determined that given the declared COVID-19 public health emergency that it was neither “feasible or appropriate” for any prior public comment into the COVID-19 vaccine guidence document. They note that comment will be accepted in accordance with the Agency’s good guidance practices, but that the FDA intended the recommendations, to be adjusted accordingly, but continue to apply “outside the context of the current public health emergency”.
This Guidence document allowed for multiple, brand new technology products, to enter a regulatory system, for which there was/is NO recognised, or established, regulatory pathway. So, under the guise of an emergency, new technology such as mRNA/LNP, DNA vectors, slipped into a “vaccine” regulatory pathway, at “warp speed”, under emergency use authorisation (EUA).
For ALL this to be legally justified, there HAD to be NO alternative treatment available
In their Jun 19, 2020 release, before any COVID-19 vaccine had ever been registered they FDA future proof the guidance document to eliminate an inert, true “placebo” group and replace it with a “vaccine control”.
If the availability of a COVID-19 vaccine proven to be safe and effective precludes ethical inclusion of a placebo control group, that vaccine could serve as the control treatment in a study designed to evaluate efficacy with non-inferiority hypothesis testing.
and
[I]n the event that a safe and effective vaccine becomes available [even if it is your own]..break the blind and offer vaccine to placebo recipients. [Which would eliminate all possible long-term safety information, the purpose for the study in the first place]
Oxford/AstraZenaca‘s COVID-19 vaccine, which wasn’t trialled in the US, used meningococcal vaccine as the control group – and the regulators accepted this!
ICAN demands the use of inert placebo control in COVID-19 vaccine trials
After a petition from ICAN to the FDA demanding the use of an inert placebo control in the COVID-19 vaccine safety trials, the FDA on 30th June issued emergency guidelines to the industry ensuring all safety trials use a placebo control.
The petition was sparked because AstraZeneca’s safety trials did not use a placebo, but a meningococcal vaccine (Menveo) [1], so ICAN sued the FDA to supply the safety studies on the Menveo vaccine, in case they intended to approve it as an active control for US EUA products.
On July 17, 2020, ICAN sued the FDA in federal court demanding the entire clinical trial report for Menveo, just in case the agency was considering permitting this vaccine as a control in the AstraZeneca trial to be conducted in the United States. [1]
“On July 20, 2020, ICAN also filed a forceful amended petition with the FDA thanking it for requiring a placebo control group but demanding, among other things, that it also require that these clinical trials track all adverse events during the entire duration of the trial – not just for a limited time period.”
“Not long thereafter, in mid-September, in a highly unusual move, the full clinical trial protocols for the COVID-19 vaccines for which ICAN filed its petitions were released to the public.” [1]
FDA sets a low efficacy requirement of 50% for COVID-19 vaccines, WHO sets 70%
In a press release on June 30, 2020 the US FDA issued guidance to manufacturers “help facilitate the timely development of safe and effective vaccines to prevent COVID-19” in order to win regulatory approval. [7]
“The guidance also discusses the importance of ensuring that the sizes of clinical trials are large enough to demonstrate the safety and effectiveness of a vaccine. It conveys that the FDA would expect that a COVID-19 vaccine would prevent disease or decrease its severity in at least 50% of people who are vaccinated.” Also the vaccine companies would be required to monitor the vaccine’s performance after approval for any emerging safety problems. [1, 2, 3]
“If you had a 60 or 70 percent effective vaccine and everybody took it, you might actually be reaching toward herd immunity and potentially then dampen down this pandemic,” Dr George Poland of the Mayo Clinic said on Nov 3, 2020.
As a comparison the flu vaccine effectiveness which “can vary widely from year to year has been anywhere from 20% to 60% effective over the last decade.
According to GlobalData on April 9, 2020 the WHO sets two vaccine success benchmarks for vaccines. “Preferably, the vaccine should have at least a 70% efficacy on a population basis with durability for at least a year for reactive use in an outbreak and/or protection for those with a high ongoing risk. The lower success bar is about 50% efficacy with at least a six-month durability”. [4]
They go on to state: “The 50% success bar, while low, is acceptable, as it would likely be enough to ease the pressure on frontline healthcare resources but it may not be high enough to reach herd immunity.”[6]
FDA commissioner Dr Stephen Hahn in a JAMA interview on July 30, 2020, stated “We all want a vaccine tomorrow. That’s unrealistic. And we all want a vaccine that’s 100% effective. Again, unrealistic,” Hahn said “we said 50%, and the reason was because we felt that that was a reasonable floor given the pandemic.” [5]
A couple of days earlier, Dr Anthony Fauci said he would like 60% meaning on average the vaccine reduces a person’s risk of SARS-CoV-2 infection by 60%.
ICAN demands FDA mandate inert placebo controls in COVID-19 vaccine clinical trials
Upon finding out AstraZeneca COVID-19 Vaccine clinical trials were not using a placebo control, but a neningococcal vaccine (Menveo) as a “control”, the Informed Consent Action Network (ICAN) a non-profit organisation, petitioned the FDA to mandate inert placebo control groups in US COVID-19 vaccine clinical trials, as well as track the safety for the long-term in properly sized trial groups. [1, 2]
Nine days after ICAN filed its initial petition, on June 30, 2020, the FDA changed course and issued emergency guidance to industry that all COVID-19 clinical trials must use a placebo control.
Later ICAN sued the FDA to supply the safety studies on the Menveo vaccine, in case they intended to approve it as an active control for US EUA products.
Many don’t realise using another vaccine for the “control” group to assess “vaccine safety”, is a common and accepted practice.
They don’t use inert placebo controls. This is why post marketing surveillance is so important, but the authorities have failed in their duty.
Africa: says no to being “guinea pigs”
Unknown to the western world is that African’s has a history of being experimented on by the WHO without consent, and in July 2020 they stood up against the first COVID-19 vaccine trial in their country by burning their masks in protest. The University of Oxford vaccine trial began in Johannesburg in June 2020. [@11:30]
“The people chosen as volunteers for the vaccination, they look as if they’re from poor backgrounds, not qualified enough to understand” protest organizer Phapano Phasha told The Associated Press ahead of the event. “We believe they are manipulating the vulnerable.”” [1]
Anti-vaccine sentiment in Africa is “the worst I’ve ever seen,” said Seth Berkley the CEO of the GAVI vaccine alliance.
“If you want to test, test in the areas which they call the epicenter of the world”
demonstrator Sean Goss said“We not guinea pigs” and “No safe vaccine” was chanted
Budesonide: Treating COVID-19 Symptoms
Emergency room doctor, Dr Richard Bartlett alerted the world to his success in treating breathing issues of COVID-19 suspected patients with nebulised budesonide – a known asthma drug that happens to be off-patent and as such cheap.
January 2021, clinical trials by Oxford Univesity now proves the benefits and safety of budesonide.
Find out more >>>
NIAID launch the COVID-19 Prevention Trials Network (COVPN)
On July 8, 2020 the US National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) launched a new clinical trials network to enrol volunteers for large-scale clinical trials testing a variety of investigational vaccines and monoclonal antibodies intended to protect people from COVID-19.
Called the COVID-19 Prevention Trials Network (COVPN) it was the merging of 4 existing NIAID-funded clinical trials networks – 3 for AIDS plus the Infectious Diseases Clinical Research Consortium (IDCRC).
Within a few weeks they were conducting clincal trial for Moderna‘s vaccine.
The NIAID stated that vaccine generated antibodies will be “different” to antibodies generated from natuaral infection with SARS-CoV-2!! Antibody tests approved were only those that detected the nucleocapsid, if they targeted “spike antigens” then the immunized person would return a positive result!
In 2020 COVPN were conducting clinical trials for:
- Moderna’s mRNA-1273 vaccine, The COVE Study™
- Regeneron’s 10933 and 10987 Antibodies, the REGN-COV2 Study
- Eli Lilly’s LY3819253 Antibody, the BLAZE-2 Study
- Pfizer & BioNTech’s BNT162b2 COVID-19 mRNA investigational vaccine
- The ENSEMBLE Study with Janssen’s Ad26.COV2.S Investigational Vaccine
- AstraZeneca Investigational COVID-19 vaccines AZD1222
International German Corona Investigation Committee begins
The Corona Investigative Committee comprising 4 lawyers led by German-American lawyer Reiner Fuellmich was initiated. Weekly hearings with international experts have taken place in order to document the scientific, political, psychological and economic connections surrounding the global COVID-19 pandemic events, capturing it in video testimony. [1, 2, 3]
WHO hires PR firm to influence opinion
WHO hires the PR firm Hill and Knowlton Strategies LLC to help ‘amplify’ the message. [1]
Soft power influence (through stealth):
- Celebrities from around the world to perform virtual “One World Concert“
- Celebrities used in ‘#PasstheMic to the experts” message.
- Religious leaders.
Fauci admits PCR amplified above 35 cycles is just “dead nucleotides”
On July 16, 2020 Dr Anthony Fauci is interviewed by This Week in Virology (TWiV) and states that high PCR cycle thresholds above 35 is just picking up “dead nucleotides” – meaning the person is not infectious. [1]
Around the world, labs were instructed to amplify PCR tests of nasal swabs for SARS-CoV-2 up to 45 cycles – proven to create masses of false positives or turning healthy people into “a ‘silent epidemic’ of asymptomatic infections” – except they’re not asymptomatic, nor infectious [2]
UK experts warn the virus is here to stay – endemic
On July 21, 2020, in an address to the House of Commons’ Health Committee, Wellcome Trust Director Sir Jeremy Farrar, stated that although progress has been made, there is no chance of this year’s holiday being like the last. [1]
“This infection is not going away, it’s now a human endemic infection,”…”Even, actually, if we have a vaccine or very good treatments, humanity will still be living with this virus for very many, many years…[Even] decades to come,” said Jeremy Farrar
“The reality is that this pathogen is here forever, [and] it isn’t going anywhere,” said Sir John Bell, University of Oxford
Timeline pages:
1800s | 1900-1945 | 1946-1979 | 1980-1999 | 2000-2015 | 2016-2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025